top of page
Fzata Lead BioPYM Candidates for Gastrointestinal Disorders


The Company is honored to have received extraordinary grant
support from NIH validating the BioPYM approach.
Imagined BioPYM
Future Product
Fzata welcomes collaboration with prominent biotech and pharmaceutical firms to address complex therapeutic objectives of shared interest, utilizing complementary skills to identify and create innovative biologic solutions for patients globally. Our strategic alliances are founded on common goals, promoting innovation through collaborative research, co-development, and access to state-of-the-art technologies and resources. We aim to maximize our impact, facilitate groundbreaking discoveries, and provide transformative healthcare solutions more swiftly and effectively in collaboration with pharma partners.
bottom of page